Nephros Free Cash Flow Per Share from 2010 to 2024

NEPH Stock  USD 2.20  0.13  5.58%   
Nephros' Free Cash Flow Per Share is increasing with slightly volatile movements from year to year. Free Cash Flow Per Share is estimated to finish at 0.08 this year. Free Cash Flow Per Share is the amount of cash Nephros generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
0.07240504
Current Value
0.076
Quarterly Volatility
53.40886744
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nephros financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nephros main balance sheet or income statement drivers, such as Depreciation And Amortization of 397.9 K, Interest Expense of 1.9 K or Total Revenue of 14.9 M, as well as many exotic indicators such as Price To Sales Ratio of 2.4, Dividend Yield of 0.0134 or PTB Ratio of 3.48. Nephros financial statements analysis is a perfect complement when working with Nephros Valuation or Volatility modules.
  
This module can also supplement various Nephros Technical models . Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

Latest Nephros' Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Nephros over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Nephros' Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nephros' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Nephros Free Cash Flow Per Share Regression Statistics

Arithmetic Mean(14.47)
Coefficient Of Variation(369.20)
Mean Deviation25.74
Median(0.53)
Standard Deviation53.41
Sample Variance2,853
Range208
R-Value0.44
Mean Square Error2,472
R-Squared0.20
Significance0.1
Slope5.28
Total Sum of Squares39,935

Nephros Free Cash Flow Per Share History

2024 0.076
2023 0.0724
2022 -0.33
2021 -0.15
2020 -0.79
2019 -0.3
2018 -0.53

About Nephros Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Nephros income statement, its balance sheet, and the statement of cash flows. Nephros investors use historical funamental indicators, such as Nephros's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Nephros investors may use each financial statement separately, they are all related. The changes in Nephros's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nephros's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Nephros Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Nephros. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 0.07  0.08 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Nephros Stock analysis

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.272
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.